COMMUNIQUÉS West-GlobeNewswire

Anaptys to Present at Guggenheim’s 6th Annual Biotechnology Conference
31/01/2024
SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president [...]
NeurAxis Appoints Timothy Henrichs as Chief Financial Officer
31/01/2024
CARMEL, Ind., Jan. 31, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS) (“NeurAxis” or the “Company”), a medical technology company commercializing neuromodulation therapies that address chronic and [...]
Simple Announces Restaurant Menu Nutrition Scores to Empower Members to Make Healthy Eating Decisions Anywhere, Anytime
31/01/2024
New product feature enables members to enjoy dining out without compromising 2024 health and wellness goals LIMASSOL, Cyprus, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Simple , the nutrition and wellness app empowering people [...]
New Philips Mini TEE ultrasound transducer helps improve cardiac care for more patients
31/01/2024
January 31, 2023 Latest innovation has the potential to reduce anesthesia during minimally invasive procedures [1] As a pioneer and leading innovator in cardiac ultrasound, Philips has developed the smaller X11- 4t Mini [...]
Editas Medicine to Participate in Upcoming Investor Conferences
31/01/2024
CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that management will participate in the following upcoming investor [...]
Autonomix Medical, Inc. to Ring the Nasdaq Stock Market Closing Bell on Thursday, February 1, 2024
31/01/2024
THE WOODLANDS, TX., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how [...]
Kane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel Spray
31/01/2024
Kane will introduce its unique spray gel at the Boswick Burn and Wound Care Symposium WINNIPEG, Manitoba, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “ [...]
Veru to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
31/01/2024
MIAMI, FL, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing novel medicines for obesity, oncology, and viral induced acute respiratory [...]
Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
31/01/2024
SAN DIEGO and LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT ) ("Conduit"), a multi-asset, clinical-stage life science company delivering an efficient model for compound development [...]
Total number of voting rights and capital on January 31, 2024
31/01/2024
Total number of voting rights and capital on January 31, 2024 January 31, 2024 Company announcement No. 05 Referring to company announcement 02, on January 29, 2024, where Novozymes A/S ("Novozymes") announced the [...]
Outlook Therapeutics® Doses First Subject in NORSE EIGHT
31/01/2024
NORSE EIGHT clinical trial is being conducted under Special Protocol Assessment (SPA) from FDA to support expected resubmission of the ONS-5010 Biologics License Application (BLA) by the end of CY2024, if successful [...]
Ocugen to Present at Pharma Market Research Conference
31/01/2024
MALVERN, Pa., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and [...]
Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
31/01/2024
FLORHAM PARK, N.J., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, [...]
Arcutis to Present at the Guggenheim Healthcare Talks – 6th Annual Biotechnology Conference
31/01/2024
WESTLAKE VILLAGE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
USGI Medical Receives FDA Approval to Conduct Pivotal Study of the POSE2.0® Incisionless Weight Loss Procedure for Primary Obesity
31/01/2024
– Approval of IDE advances Company’s progress to make endoscopic gastroplasty an essential element of the primary obesity treatment algorithm – SAN CLEMENTE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- USGI Medical, Inc [...]
Merus to Participate in Upcoming Investor Conferences
31/01/2024
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Merus N.V . (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and [...]
Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference
31/01/2024
SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will participate in the BTIG Snowbird MedTech, [...]
Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024
31/01/2024
There are no FDA-approved treatments for female sexual arousal disorder SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, and its collaborator [...]
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
31/01/2024
WARRINGTON, Pa., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for critical [...]

Pages